Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>Products>Product News
  Service News
Expert System Optimizes Discovery of Drugs
Tuesday, April 07, 2015
Pharmaceutical companies use the expert system IMPACT-F to forecast drug-uptake in humans.

High ThroughputPARP in vivo Pharmacodynamic Assay
Monday, February 23, 2015
AMSBIO has introduced a unique High Throughput PARP in vivo Pharmacodynamic Assay that can be used to monitor the efficacy of poly-ADP-ribose polymerase (PARP) inhibitors on PAR formation in vivo; and to measure drug action on PARP in both in vivo and in vitro settings.

Vetter Development Service Chicago is Now Ready for Realizing Clinical Syringe Projects
Friday, December 12, 2014
Recent facility expansion offers new manufacturing options and additional filling capacity.

Imperial Innovations Leads £50 Million Series B Funding Round in Cell Medica
Tuesday, November 25, 2014
Cell Medica will use the investment capital to progress further the development of cellular immunotherapy products.

Clustering Effect Translates into Major Growth for BioPharma Specialist
Saturday, October 25, 2014
Company manages translation and linguistic validation projects.

New Accessories for the Mastersizer 3000 from Malvern Instruments
Friday, October 17, 2014
New accessories support smarter pharmaceutical particle size analysis.

FUJIFILM Diosynth Biotechnologies Announces the Launch of ‘Apollo™’
Thursday, October 09, 2014
New mammalian expression platform designed to create a robust ‘manufacturing-ready’ cell line.

The Lancet: Remote Monitoring Can Save ICD and CRT-D Patients' Lives
Tuesday, August 19, 2014
BIOTRONIK Home Monitoring reduces mortality and improves clinical outcomes in patients with heart failure.

Eurofins Genomics Adds NGS to ISO17025 Accredited Testing Portfolio
Saturday, August 16, 2014
ISO17025 accreditation to consistently offer valid results for testing in the fields of veterinary medicine, pharmaceuticals, food and animal feed, commodities and health care.

<< 1 2 3 4 5 6 7 >>
Showing Results 11 - 20 of 309
Scientific News
Liquid Biopsies: Utilization of Circulating Biomarkers for Minimally Invasive Diagnostics Development
Market Trends in Biofluid-based Liquid Biopsies: Deploying Circulating Biomarkers in the Clinic. Enal Razvi, Ph.D., Managing Director, Select Biosciences, Inc.
Study Questions Presence in Blood of Heart-Healthy Molecules from Fish Oil Supplements
A new study from the Perelman School of Medicine at the University of Pennsylvania questions the relevance of fish oil-derived SPMs and their purported anti-inflammatory effects in humans.
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
Young South African Women can Adhere to Daily PrEP Regimen as HIV Prevention
NIH-funded study finds men in Bangkok, Harlem also successful in taking daily dose.
Key Player in Diabetic Kidney Disease Revealed
Discovery could lead to new and better diagnostic marker for chronic kidney disease.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Santhera Announces First Patient Dosing with Omigapil in CMD
Company announces full patient recruitment of CALLISTO study.
Study Shows Promise of Precision Medicine for Most Common Type of Lymphoma
The study appeared online July 20, 2015, in Nature Medicine.
HIV Control Through Treatment Durably Prevents Heterosexual Transmission of Virus
NIH-funded trial proves suppressive antiretroviral therapy for HIV-infected people effective in protecting uninfected partners.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!